Disclosed positions

Estimated from their latest filings — positions may have changed since

$29.87M

combined est. value

Stock	Shares	Price	Value	Weight	As of
AUPHAurinia Pharmaceuticals Inc.	1,840,379	$16.23	$29.87M	100%	2026-03-02

AUPH

Aurinia Pharmaceuticals Inc.

$29.87M

1,840,379 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
AUPHAurinia Pharmaceuticals Inc.	Tax $1.43M · 100,890 sh	2026-03-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 196,403 sh	2026-02-27	—
AUPHAurinia Pharmaceuticals Inc.	Tax $1.44M · 100,171 sh	2026-02-20	—
AUPHAurinia Pharmaceuticals Inc.	Tax $1.81M · 113,169 sh	2026-01-02	—
AUPHAurinia Pharmaceuticals Inc.	Grant — · 165,384 sh	2026-01-02	—

AUPHTax

2026-03-02 · Aurinia Pharmaceuticals Inc.

$1.43M

—

AUPHGrant

2026-02-27 · Aurinia Pharmaceuticals Inc.

196,403

—

AUPHTax

2026-02-20 · Aurinia Pharmaceuticals Inc.

$1.44M

—

AUPHTax

2026-01-02 · Aurinia Pharmaceuticals Inc.

$1.81M

—

AUPHGrant

2026-01-02 · Aurinia Pharmaceuticals Inc.

165,384

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.